NCT04945226View on ClinicalTrials.gov

A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

February 8, 2022

Study Completion Date

February 8, 2022

Conditions
Androgenetic Alopecia
Interventions
DRUG

Finasteride 1mg Tablet

Propecia Tablet 1mg

DRUG

IVL3001

Finasteride long acting injection

Trial Locations (1)

Unknown

Nucleus Network, Brisbane

Sponsors
All Listed Sponsors
lead

Inventage Lab., Inc.

INDUSTRY